Please login to the form below

Not currently logged in
Email:
Password:

venture capital

This page shows the latest venture capital news and features for those working in and with pharma, biotech and healthcare.

Gyroscope advances gene therapy platform, merges with Orbit

Gyroscope advances gene therapy platform, merges with Orbit

Syncona's Chris Hollowood. Both companies have been backed by Syncona, a venture capital firm focused on life sciences, including a host of UK-based cell and gene therapy firms.

Latest news

More from news
Approximately 1 fully matching, plus 90 partially matching documents found.

Latest Intelligence

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    The venture capital approach to dementia research. The Dementia Discovery Fund is a venture capital fund focused on discovering and developing novel therapies for dementia, first set up in October 2015. ... The global consortium aims to take a biotech

  • AI UK – one year on AI UK – one year on

    States. 1. Published in January 2018, our work found that despite great excitement for healthcare AI in tech and venture capital communities, patients themselves were at best only cautiously embracing the

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    Money flowing into Europe. Meanwhile, just as multinationals are increasing their investments in China, there is also a huge amount of investment capital flowing out of China, and into European and ... Venture capital funds based in China invested $1.4bn

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    19. Kate Bingham, Managing Partner, SV Life Sciences. Kate is one of the best-known faces in UK biotech venture capital, which plays an increasingly important part in the life sciences

  • When is it time to rebrand? When is it time to rebrand?

    Four critical success factors for brand initiatives are:. Readiness - Companies need to be ready to invest their focus, capital and human resources. ... We need to raise venture capital. We’ve had a crisis and we need to reset.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics